New cell therapy trial offers hope for tough blood cancers
NCT ID NCT07070219
Summary
This study is testing an experimental cell therapy called CTD402 for people aged 12 and older whose T-cell leukemia or lymphoma has come back or hasn't responded to other treatments. Participants receive a single infusion of these specially modified immune cells and are then monitored closely for safety and to see if the treatment shrinks or eliminates the cancer. The goal is to see if this approach can help control these aggressive cancers when standard options have failed.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOCYTIC LEUKEMIA REFRACTORY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Colorado Blood Cancer Institute
NOT_YET_RECRUITINGDenver, Colorado, 80218, United States
Contact
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Email: •••••@•••••
-
Mayo Clinic - Rochester
NOT_YET_RECRUITINGRochester, Minnesota, 55905, United States
-
Memorial Sloan Kettering Cancer Center
RECRUITINGNew York, New York, 11101, United States
Contact
-
Montefiore Einstein Comprehensive Cancer Center
RECRUITINGThe Bronx, New York, 10467, United States
Contact
-
Sarah Cannon Research Insitute
RECRUITINGNashville, Tennessee, 37203, United States
Contact Phone: •••-•••-••••
-
Stanford University
RECRUITINGPalo Alto, California, 94304, United States
Contact Email: •••••@•••••
-
University of Chicago
NOT_YET_RECRUITINGChicago, Illinois, 60637, United States
Conditions
Explore the condition pages connected to this study.